Product Details for NDA 018063
CORGARD (NADOLOL)
20MG
Marketing Status: Prescription
40MG
Marketing Status: Prescription
80MG
Marketing Status: Prescription
120MG
Marketing Status: Discontinued
160MG
Marketing Status: Discontinued
20MG
Marketing Status: Prescription
Active Ingredient: NADOLOL
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018063
Product Number: 005
Approval Date: Oct 28, 1986
Applicant Holder Full Name: USWM LLC
Marketing Status: Prescription
Patent and Exclusivity Information
CORGARD (NADOLOL)
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018063
Product Number: 005
Approval Date: Oct 28, 1986
Applicant Holder Full Name: USWM LLC
Marketing Status: Prescription
Patent and Exclusivity Information
40MG
Marketing Status: Prescription
Active Ingredient: NADOLOL
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018063
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Prescription
Patent and Exclusivity Information
CORGARD (NADOLOL)
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018063
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Prescription
Patent and Exclusivity Information
80MG
Marketing Status: Prescription
Active Ingredient: NADOLOL
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N018063
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Prescription
Patent and Exclusivity Information
CORGARD (NADOLOL)
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N018063
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Prescription
Patent and Exclusivity Information
120MG
Marketing Status: Discontinued
Active Ingredient: NADOLOL
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 120MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018063
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
CORGARD (NADOLOL)
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 120MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018063
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
160MG
Marketing Status: Discontinued
Active Ingredient: NADOLOL
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 160MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018063
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CORGARD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 160MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018063
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: USWM LLC
Marketing Status: Discontinued
Patent and Exclusivity Information